CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NBY

sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate

Phase 2
NovaBay Pharmaceuticals, Inc. (NBY)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Asymptomatic Bacteriuria

View Full Landscape
Drug Information

Target Indication

Asymptomatic Bacteriuria

Clinical Trial

NCT00781339

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.